Hutchinson Michael Damon 4

What Happened
Michael Damon Hutchinson, EVP, Chief Legal Officer & Secretary of Integra Lifesciences (IART), was granted 89,606 restricted stock units (RSUs) on 2026-02-02. The grant is reported as a derivative acquisition at $0.00 (transaction code A). These RSUs do not represent vested shares today and will convert to common shares only upon vesting.

Key Details

• Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (timely filing).
• Award: 89,606 RSUs reported at $0.00 (derivative award).
• Vesting: 100% vests on the second anniversary of the grant date (02/02/2028). (Footnote F1)
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: A = Award/Grant (not a purchase or sale).

Context
This is a compensation award (RSUs) rather than an open-market purchase or sale. RSUs typically do not convey voting rights or transferable ownership until they vest and may be forfeited if vesting conditions aren’t met; they’re common executive compensation. Because the Form 4 was filed within two days of the grant date, the filing appears timely.